Literature DB >> 26931429

Tracing gadolinium-based contrast agents from surface water to drinking water by means of speciation analysis.

Marvin Birka1, Christoph A Wehe1, Oliver Hachmöller1, Michael Sperling2, Uwe Karst3.   

Abstract

In recent decades, a significant amount of anthropogenic gadolinium has been released into the environment as a result of the broad application of contrast agents for magnetic resonance imaging (MRI). Since this anthropogenic gadolinium anomaly has also been detected in drinking water, it has become necessary to investigate the possible effect of drinking water purification on these highly polar microcontaminats. Therefore, a novel highly sensitive method for speciation analysis of gadolinium is presented. For that purpose, the hyphenation of hydrophilic interaction liquid chromatography (HILIC) and inductively coupled plasma-mass spectrometry (ICP-MS) was employed. In order to enhance the detection power, sample introduction was carried out by ultrasonic nebulization. In combination with a novel HILIC method using a diol-based stationary phase, it was possible to achieve superior limits of detection for frequently applied gadolinium-based contrast agents below 20pmol/L. With this method, the contrast agents Gd-DTPA, Gd-DOTA and Gd-BT-DO3A were determined in concentrations up to 159pmol/L in samples from several waterworks in a densely populated region of Germany alongside the river Ruhr as well as from a waterworks near a catchment lake. Thereby, the direct impact of anthropogenic gadolinium species being present in the surface water on the amount of anthropogenic gadolinium in drinking water was shown. There was no evidence for the degradation of contrast agents, the release of Gd(3+) or the presence of further Gd species.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contrast agents; Drinking water; Gadolinium; LC-ICP-MS; Speciation analysis

Mesh:

Substances:

Year:  2016        PMID: 26931429     DOI: 10.1016/j.chroma.2016.02.050

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

2.  Removal of gadolinium-based contrast agents: adsorption on activated carbon.

Authors:  María P Elizalde-González; Esmeralda García-Díaz; Mario González-Perea; Jürgen Mattusch
Journal:  Environ Sci Pollut Res Int       Date:  2017-01-31       Impact factor: 4.223

3.  Evaluation of superficially and fully porous particles for HILIC separation of lanthanide-polyaminocarboxylic species and simultaneous coupling to ESIMS and ICPMS.

Authors:  E Blanchard; A Nonell; F Chartier; A Rincel; C Bresson
Journal:  RSC Adv       Date:  2018-07-09       Impact factor: 4.036

4.  Variations of anthropogenic gadolinium in rivers close to waste water treatment plant discharges.

Authors:  Marc Parant; Emilie Perrat; Philippe Wagner; Christophe Rosin; Jean-Sebastien Py; Carole Cossu-Leguille
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-26       Impact factor: 4.223

Review 5.  Elemental Speciation Analysis in Environmental Studies: Latest Trends and Ecological Impact.

Authors:  Mauricio Llaver; Emiliano F Fiorentini; María N Oviedo; Pamela Y Quintas; Rodolfo G Wuilloud
Journal:  Int J Environ Res Public Health       Date:  2021-11-19       Impact factor: 3.390

6.  Gadolinium-based contrast agent accelerates the migration of astrocyte via integrin αvβ3 signaling pathway.

Authors:  Winda Ariyani; Wataru Miyazaki; Yoshito Tsushima; Noriyuki Koibuchi
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

Review 7.  Facets of ICP-MS and their potential in the medical sciences-Part 1: fundamentals, stand-alone and hyphenated techniques.

Authors:  David Clases; Raquel Gonzalez de Vega
Journal:  Anal Bioanal Chem       Date:  2022-08-27       Impact factor: 4.478

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.